Myron M Kwapisz, Christoph Neuhäuser, Stephan Scholz, Ingeborg D Welters, Tobias Löhr, Tillo Koch, Klaus Valeske, Hakan Akintürk, Josef Thul, Matthias Müller
文献索引:Paediatr. Anaesth. 19(9) , 862-71, (2009)
全文:HTML全文
After surgical repair of congenital heart disease, inotropic support is sometimes necessary to wean from cardiopulmonary bypass. In pediatric cardiac surgery, dobutamine and dopamine are often used as inotropic support. Dopexamine is a synthetic catecholamine, which has positive inotropic and vasodilating properties. Because the hemodynamic effects of catecholamines are modified after cardiopulmonary bypass, the aim of this study was to investigate the effects of dobutamine and dopexamine on cardiac index and systemic vascular resistance index after cardiopulmonary bypass in pediatric cardiac surgery.The study was performed in a prospective, randomized, and double-blinded cross-over design. The investigation included 11 children for elective, noncomplex congenital heart surgery. After weaning from cardiopulmonary bypass and a 20-min period of steady state, children received either 2.5 microg x kg(-1) x min(-1) dobutamine or 1 microg x kg(-1) x min(-1) dopexamine for 20 min. Cardiac index (transpulmonary thermodilution), mean arterial pressure, central venous pressure, stroke volume, systemic vascular resistance, and central venous oxygen saturation were determined. The primary outcome variable was cardiac index.No difference in cardiac index was observed between the two groups (P = 0.594). Both drugs increased cardiac index, dopexamine from 3.9 +/- 0.6 to 4.7 +/- 0.8 l x min(-1) x m(-2) (P = 0.003) and dobutamine from 4.1 +/- 0.7 to 4.8 +/- 0.7 l x min(-1) x m(-2) (P = 0.004). During treatment with dobutamine, children presented with significantly higher mean arterial pressure (P = 0.003) and systemic vascular resistance index (P = 0.026).This trial demonstrates that low-dose dobutamine and dopexamine both increase cardiac index during pediatric cardiac surgery but with different hemodynamic effects.
| 结构式 | 名称/CAS号 | 分子式 | 全部文献 |
|---|---|---|---|
![]() |
盐酸多培沙明
CAS:86484-91-5 |
C22H34Cl2N2O2 |
|
The effect of fenoldopam and dopexamine on cytokine and endo...
2010-12-01 [Heart Surg. Forum 13(6) , E353-61, (2010)] |
|
Is dopexamine superior to dopamine in the treatment of multi...
2010-01-01 [Injury 41(5) , 499-505, (2010)] |
|
Dopexamine Test in septic shock with hyperlactatemia.
2010-11-01 [Ann. Fr. Anesth. Reanim. 29(11) , 759-64, (2010)] |
|
Comparison of systemic and renal effects of dopexamine and d...
2006-04-01 [J. Cardiothorac. Vasc. Anesth. 20(2) , 173-8, (2006)] |
|
Inotropic therapy for cardiac low output syndrome: compariso...
2008-10-27 [Eur. J. Med. Res. 13(10) , 459-63, (2008)] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved
